Revenue Estimates Analysis of DPW Holdings, Inc.(NYSE:DPW): Synthetic Biologics, Inc(NYSE:SYN)

0
4

Many analysts are providing their Estimated Earnings analysis for DPW Holdings, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

DPW Holdings, Inc. closed its last trading session at $0.14 with the loss of -4.57%. The Market Capitalization of the company stands at 5.09 Million. The Company has 52-week high of $13.79 and 52-week low of $0.14. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -13.44% where SMA50 and SMA200 are -33.65% and -95.84% respectively. The Company Touched its 52-Week High on 06/15/18 and 52-Week Low on 06/12/19.

The Relative Volume of the company is 0.6 and Average Volume (3 months) is 3.74 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -62.6%. The Return on Equity (ROE) value stands at -139.6%. While it’s Return on Investment (ROI) value is -60.5%.

While looking at the Stock’s Performance, DPW Holdings, Inc. currently shows a Weekly Performance of -10.85%, where Monthly Performance is -33.62%, Quarterly performance is -91.72%, 6 Months performance is -96.11% and yearly performance percentage is -98.91%. Year to Date performance value (YTD perf) value is -93.25%. The Stock currently has a Weekly Volatility of 9.05% and Monthly Volatility of 10.76%.

Synthetic Biologics, Inc (SYN) will report its next earnings on May 29 AMC. The company reported the earnings of $-0.28/Share in the last quarter where the estimated EPS by analysts was $-0.23/share. The difference between the expected and actual EPS was $-0.05/share, which represents an Earnings surprise of -21.7%.

Many analysts are providing their Estimated Earnings analysis for Synthetic Biologics, Inc and for the current quarter 1 analysts have projected that the stock could give an Average Earnings estimate of $-0.23/share. These analysts have also projected a Low Estimate of $-0.23/share and a High Estimate of $-0.23/share.

Some buy side analysts are also providing their Analysis on Synthetic Biologics, Inc, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Synthetic Biologics, Inc might touch $2.25 high while the Average Price Target and Low price Target is $2.25 and $2.25 respectively.

Synthetic Biologics, Inc closed its last trading session at $0.49 with the gain of 0.55%. The Market Capitalization of the company stands at 8.15 Million. The Company has 52-week high of $9.08 and 52-week low of $0.49. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -8.65% where SMA50 and SMA200 are -15.81% and -49.62% respectively. The Company Touched its 52-Week High on 07/02/18 and 52-Week Low on 06/10/19.

The Relative Volume of the company is 0.32 and Average Volume (3 months) is 234.12 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -141.5%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Synthetic Biologics, Inc currently shows a Weekly Performance of -4.08%, where Monthly Performance is -14.83%, Quarterly performance is -28.41%, 6 Months performance is -29.41% and yearly performance percentage is -93.86%. Year to Date performance value (YTD perf) value is -11.79%. The Stock currently has a Weekly Volatility of 5.18% and Monthly Volatility of 4.85%.

SHARE